top of page

Search Results

Results found for "opioid pharmacology"

  • 📰 GPCR Weekly News, March 25 to March 31, 2024

    Samuel Hoare on Advanced data analysis for GPCR pharmacology, which will be held on Thursdays between Terry Kenakin’s Applying Pharmacology to Drug Discovery course. Continue to increase your knowledge of Pharmacology by joining this practical approach class today. promotes the restoration of tension in epithelial cells Profiling the proximal proteome of the activated μ-opioid Research Fellow Postdoctoral Fellow – Molecular Pharmacology of Feeding Behavior Director of Laboratory

  • 📰 GPCR Weekly News - January 9 to 15, 2023

    molecular associations in clathrin-coated pit regulate β-arrestin-mediated MAPK signaling downstream of μ-opioid Deadline February 12, 2023 Current Technologies To Understand G-Protein-Coupled Receptor Molecular Pharmacology (June 4-8, 2023). 2023 Molecular Pharmacology (GRS) Seminar GRC. (June 10 -11, 2023). (June 11-16, 2023). 19th World Congress of Basic & Clinical Pharmacology 2023. (July 2 - 7). Biotechnology and Biological Sciences Doctoral Training Programme Senior QM Manager Director of Molecular Pharmacology

  • Hop in the Time Machine with GPCR: Unraveling the Future of Research! ⦿ Nov 24 - Dec 1, 2024

    | BIO International Convention 2025 July 12 - 17, 2026 | 20th World Congress of Basic and Clinical Pharmacology Principal Scientist, Medicinal Chemistry PhD fellowship in GPCR mechanosensing Senior Scientist, GPCR Pharmacology Research Associate - Professor Graeme Milligan Postdoc in Molecular Pharmacology - The Hauser Group protein-coupled receptor (GPCR) pharmacogenomics Antibodies expand the scope of angiotensin receptor pharmacology ameliorates l-DOPA induced dyskinesia in hemiparkinsonian mice GPR88 impairs the signaling of kappa opioid

  • 📰 GPCR Weekly News, February 26 to March 3, 2024

    GPCR University Course, ‘Applying Pharmacology to Drug Discovery,’ led by Dr. of potential TAAR1 agonist targeting neurological and psychiatric disorders: An in silico approach Opioid , 2024 | 11th Adhesion GPCR Workshop July 12 - 17, 2026 | 20th World Congress of Basic and Clinical Pharmacology Research Unit Postdoctoral Scholar – Synaptic physiology, optical imaging, substance use disorder, pharmacology Research Fellow Postdoctoral Fellow – Molecular Pharmacology of Feeding Behavior Director of Laboratory

  • 📰 GPCR Weekly News, October 9 to 15, 2023

    fungus GPCR Binders, Drugs, and more Development of Photoswitchable Tethered Ligands that Target the µ-Opioid Chemotactic Cytokines GPCR Jobs NEW Head of Human Resource Business Partners Senior Scientist, In vitro pharmacology - Crinetics Pharmaceuticals Senior Director, In vitro pharmacology - Crinetics Pharmaceuticals In vivo Antibody Discovery Research Scientist In Vitro Biologist/Molecular Pharmacologist Senior Vice President

  • Knowing When to Walk, Knowing When to Run: Lessons from the Bench

    A Final Aha Moment: Try the Crazy Idea When a collaborator offered a neuroma model (one where opioids

  • 📰 GPCR Weekly News

    Exploring pharmacological inhibition of Gq/11 as an analgesic strategy. Molecular insights into the mechanism of sugar-modified enkephalin binding to opioid receptors. Current Technologies To Understand G-Protein-Coupled Receptor Molecular Pharmacology. June 4-8,2023. 2023 Molecular Pharmacology (GRS) Seminar GRC. June 10 - 11. June 11-16, 2023. 19th World Congress of Basic & Clinical Pharmacology 2023. July 2 - 7.

  • Search for safer pain relief advances with new engineered compounds

    November 2021 "Chronic use of most opioids causes tolerance; the new compounds avoid this and other unwanted new pain-relieving compounds that, like morphine and other drugs, provide relief via activation of opioid receptors, but without inducing many dangerous and unwanted side-effects that have driven opioid-related

  • 📰 GPCR Weekly News, January 30 to February 5, 2023

    Pharmacological characterization of novel small molecule agonists and antagonists for the orphan receptor Patching holes in the mechanism of opioid tolerance. (June 4 - 8, 2023). 2023 Molecular Pharmacology (GRS) Seminar GRC. (June 10 - 11, 2023). (June 11 - 16, 2023). 19th World Congress of Basic & Clinical Pharmacology 2023. PhD student at Department of Drug Design and Pharmacology Software / database development postdoc at

  • Regulators of G-protein signaling: essential players in GPCR signaling

    For example, μ opioid receptor (MOR) interacts with Gαi/o and Gαz subunits, which have a slow enzymatic Senese, N.B., et al., Regulator of G-Protein Signaling (RGS) Protein Modulation of Opioid Receptor Signaling Pharmacol Rev, 2002. 54(3): p. 527-59. https://pubmed.ncbi.nlm.nih.gov/12223533/ 4. Wang, Q., L.Y. Traynor, Differential modulation of mu- and delta-opioid receptor agonists by endogenous RGS4 protein

  • 📰 GPCR Weekly News, April 10 to 16, 2023

    In situ visualization of opioid and cannabinoid drug effects using phosphosite-specific GPCR antibodies (April 20 - 21, 2023) Swiss Biotech Day (April 24 - 25, 2023) ASPET 2023 - American Society for Pharmacology (June 4 - 8, 2023). 2023 Molecular Pharmacology (GRS) Seminar GRC. (June 10 - 11, 2023). Adrenoceptors and GPCR Signalling (June 30 - July 1, 2023) 19th World Congress of Basic & Clinical Pharmacology

  • 📰 GPCR Weekly News, December 4 to 10, 2023

    This comprehensive course covers fundamental pharmacology in four weekly segments, delving into Agonists Binders, Drugs, and more Design and structural validation of peptide-drug conjugate ligands of the kappa-opioid , 2024 | 11th Adhesion GPCR Workshop July 12 - 17, 2026 | 20th World Congress of Basic and Clinical Pharmacology

  • Inside Out: Mapping GPCRs from Membrane Codes to Market Moves

    phosphorylation barcodes shape arrestin engagement, a biased NTSR1 modulator targets pain without the need for opioids

  • GPCRs are not simple on-off switches: deep dive into GPCR-ligand interactions

    In terms of pharmacology, GPCRs have been identified to exist in at least two distinct states: an active Subsequently, opioid receptors were shown to constitutively activate Gi proteins in a membrane preparation GPCR ligands pharmacology The impact of a ligand on a receptor's structure and biophysical attributes their allosteric influence, an attribute that offers a considerable degree of adjustability in terms of pharmacological

  • 📰 GPCR Weekly News, January 29 to February 4, 2024

    GPCR University This week marks the beginning of our first Dr.GPCR University course, 'Applying Pharmacology flexible cadherin ectodomain GPCR Activation and Signaling GPCR signaling bias: an emerging framework for opioid Webinars February 11 - 14, 2024 | 2024 BPS Annual Meeting February 20, 2024 | Career Opportunities in Pharmacology , 2024 | 11th Adhesion GPCR Workshop July 12 - 17, 2026 | 20th World Congress of Basic and Clinical Pharmacology

  • VAMP2: a crucial player in the delivery of MOR to the synapse

    In addition, VAMP2 can interact with other GPCRs, such as the beta-2 adrenergic receptor and the mu-opioid with different fusion proteins and also this different molecular codes will be modulated by different opioids Conformational specificity of opioid receptors is determined by subcellular location irrespective of

  • John Streicher talks about his work on terpenes found in cannabis as these may be a novel way to ...

    These compounds may be a novel way to treat pain without the negative side effects of cannabinoids or opioids

  • 📰 GPCR Weekly News, July 17 to July 23, 2023

    GPCRs in Neuroscience Mu-opioid receptor selective superagonists produce prolonged respiratory depression Postdoctoral Fellow, Caron Lab Clinical Trial Associate Research Scientist/Senior Scientist I - Molecular Pharmacology

  • 📰 GPCR Weekly News, July 24 to July 30, 2023

    The Neuromedin U system: pharmacological implications for the treatment of obesity and binge eating behavior Profiling neuronal methylome and hydroxymethylome of opioid use disorder in the human orbitofrontal cortex

  • Chemical Drug Matter : Rethinking the Molecules We Choose to Develop In Drug Discovery

    the chemical matter  interacting with that target lacks the right properties to produce meaningful pharmacology In this lesson, you’ll gain: A strategic view of how chemical scaffolds shape pharmacologic outcomes Building on Known Pharmacology Medicinal chemists learned early that modifying endogenous molecules — It was early structure-based pharmacology. Dr. They are mainstream pharmacology.

  • 📰 GPCR Weekly News, July 31 to August 6, 2023

    RXFP1 signals through a mechanism of autoinhibition To probe the activation mechanism of the Delta opioid 2024) GPCR Jobs NEW Director, Regulatory Affairs NEW Research Scientist/Senior Scientist I - Molecular Pharmacology

  • Chronic itch: emerging treatments following new research concepts

    Currently, inhibitors of IL-31, IL-4/13, NK1 receptors, opioids and cannabinoids, JAK, PDE4 or TRP are

  • Embark on a GPCR Adventure: Your Weekly Research Expedition! | Oct 21-27, 2024

    Allosteric GPCR Binding Sites and Their Ligandability Potential Today, we started the Principles of Pharmacology Emerging Voices in GPCR Biology in Special Issue of Molecular Pharmacology GPCR Events, Meetings, and GPCRs-Targeted Drug Discovery Summit Europe July 12 - 17, 2026 | 20th World Congress of Basic and Clinical Pharmacology GPCR Jobs Scientist I Cell Biology - Tectonic Therapeutic Senior Scientist, GPCR Pharmacology Research Associate - Professor Graeme Milligan Postdoc in Molecular Pharmacology - The Hauser Group Postdoctoral

  • Dr. GPCR Spotlights Revvity’s pHSense™ Internalization Tools

    The reagents are compatible with HTRF readers  and validated in GLP1R  and Mu opioid receptor (MOR)  

  • What If the Most Important Part of Your Drug Isn’t What It Binds—But What It Does?

    Terry walks you through real-world experiments, decades of receptor pharmacology wisdom, and the cutting-edge 🔓 Find the lesson in Terry’s Pharmacology Vault: “Efficacy and System Sensitivity Unlock "Agonism &

  • Understanding Orthosteric Binding: The Key to Drug Action

    The Importance of Binding in Drug Action In pharmacology, binding must happen before any drug effect potency, but this isn't always the case due to various biological factors. 📚 Whether you're new to pharmacology You'll gain valuable insights into the critical role binding plays in pharmacology. Understanding the intricate details of drug-receptor interactions transforms how we approach pharmacology

  • Confo Therapeutics Doses First Subjects In Phase 1 Clinical Trial Of CFTX-1554 For The Treatment ...

    CFTX-1554 is being developed as a non-opioid approach to the treatment of neuropathic pain, a debilitating

  • Transformative GPCR Insights: Unleash New Horizons in Science | Sep 9 - 15, 2024

    🚨 Hurry to reserve your spot for the Principles of Pharmacology I & II BUNDLE before the Early Every Thursday at 10 AM EST: Principles of Pharmacology I Dates: October 3, 10, 17, 24 (four sessions ) Topics: Pharmacologic activity measurement, mechanisms of action, and GPCR discovery strategies. Registration deadline: September 27, 2024 Principles of Pharmacology II Dates: October 31, November Emerging Voices in GPCR Biology in Special Issue of Molecular Pharmacology GPCR Events, Meetings, and

  • Ever Wondered How Drugs Are Discovered?

    Terry Kenakin , a veteran pharmacologist with over 40 years of industry experience. If you're just beginning your pharmacology journey… This is the lesson that will connect the dots. You’ll leave with the language, logic, and big-picture view that underpins all future learning in pharmacology

  • 📰 GPCR Weekly News, July 1 to 7, 2024

    Gunnar Schulte for his study on the International Union of Basic and Clinical Pharmacology. Jianming Han, Tao Che for their analysis of GPCR-G protein selectivity revealed by structural pharmacology Here’s a sneak peek at what you can expect: Principles of Pharmacology in Drug Discovery I - Techniques Principles of Pharmacology in Drug Discovery II - Advanced Methods for the Optimization of Candidate 2026 GPCR Jobs HIGHLIGHT Principal Scientist, In vitro pharmacology NEW Senior Scientist - Discovery

bottom of page